Genetic Test May Reduce Need for Repeat Biopsy for Prostate Cancer
July 17, 2012
…a genetic test to predict a man’s risk for prostate cancer. Use of the test could reduce the need for repeat biopsies in men who have had a negative biopsy.
Your search for “Prostate Cancer” returned 68 results
Renowned Surgeon Christopher J. Kane Named to Joseph D. Schmidt, MD Presidential Chair in Urology
November 16, 2015
Christopher J. Kane, M.D., a renowned specialist in prostate cancer and an expert in robotic and other minimally invasive procedures for urologic surgery at the University of California, San Diego, has been appointed the inaugural holder of the Joseph D. Schmidt, MD Presidential Chair in Urology in the School of…
New Drug Combo Targets Multiple Cancers
November 16, 2011
Researchers at the University of California, San Diego School of Medicine and Kyushu University Medical School say a novel combination of a specific sugar molecule with a pair of cell-killing drugs prompts a wide variety of cancer cell types to kill themselves, a process called apoptosis or programmed cell death.
NCI Renews Funding for San Diego Universities, Community Health Centers to Work Together
September 28, 2015
…reducing the burden of cancer among Hispanic/Latinos in San Diego and Imperial counties through research and community outreach has received a $13 million grant from the National Cancer Institute (NCI), part of the National Institutes of Health. The five-year grant renews funding for a partnership started in 2008 between San…
Evolution May Be to Blame for High Risk of Advanced Cancers in Humans
December 8, 2020
Compared to chimpanzees, our closest evolutionary cousins, humans are particularly prone to developing advanced carcinomas — the type of tumors that include prostate, breast, lung and colorectal cancers — even in the absence of known risk factors, such as genetic predisposition or tobacco use.
Christopher Kane, MD, Appointed CEO of UC San Diego Health Physicians
August 22, 2018
Christopher Kane, MD, has been appointed dean of clinical affairs for UC San Diego School of Medicine and CEO of UC San Diego Health Physicians, effective July 15. In these dual roles, Kane will collaborate with UC San Diego leadership to ensure that UC San Diego Health Physicians achieve the…
Imaging Biomarker Distinguishes Prostate Cancer Tumor Grade
June 1, 2016
…imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment…
Prostate Cancer and Blood Lipids Share Genetic Links
April 30, 2014
…contributions to levels of these blood lipids and to prostate cancer.
New Model for Active Surveillance of Prostate Cancer Tested
April 27, 2016
…a new model of care for patients with low-risk prostate cancer. The evidence-based approach uses best practices to appropriately select and follow patients to avoid disease overtreatment. Results of the three-year study are now published online in the journal of Urology.
Mission: Search and Destroy Prostate Cancer
September 21, 2020
Moores Cancer Center at UC San Diego Health is using advanced imaging, genomics, personalized medicine and new therapies to treat patients like Brian McCloskey, who has stage IV prostate cancer.
